Amyloidosis may not be as rare as you think. There is a lack of disease identification. This presentation will help raise awareness and educate on treatment strategies developed from clinical research.
Describe Amyloidosis diagnosis and subtyping, genetics, clinical manifestations, and current clinical research opportunities
MBBCh (MD), FASE, FACC,
Director of Clinical Trials,
Oregon Health and Science University
You must be logged in and own this session in order to